Iceland pushes forward with electronic leaflets
This article is powered by OTC Bulletin & The Rose Sheet
Executive Summary
Introducing electronic patient information leaflets (e-PILs) across Europe would improve patient safety and make trade easier between European countries, according to Einar Magnússon, Iceland’s representative on the Council of Europe’s pharmaceuticals and pharmaceutical care committee, the CD-P-PH.
You may also be interested in...
AESGP Conference Round-Up: Digital Disruption, Med Device Worries And The Benefits Of Switching
Speakers from the EMA and European Commission, as well as Pfizer and HRA Pharma, debated at the AESGP's Regulatory Conference the ongoing digital transformation of the European consumer healthcare market, the latest developments in the implementation of the new medical devices regulations, and the best ways to encourage Rx-to-OTC switching across the EU.
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.